HOLX241220P65000
- 0.03
- -0.03-50.00%
Hologic Newsroom
Needham Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $90
Positive Outlook for Hologic Amidst Revenue and EPS Adjustments: Analyst Recommends Buy
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
Here's Why Hologic (HOLX) Fell More Than Broader Market
Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Hologic Analyst Ratings
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
Peering Into Hologic's Recent Short Interest
FDA Announces Implantable Marker Recall: Hologic Removes BioZorb 3D Bioabsorbable Markers Due To Risk For Patient Complications
Express News | FDA: Identified Hologic's Recall as Most Serious Type; Recall Involves Removing Devices From Where They Are Used/Sold
Express News | FDA: There Have Been 252 Reported Injuries Related to Hologic's Biozorb 3D Bioabsorbable Markers
Express News | FDA: Hologic Removes Biozorb 3D Bioabsorbable Markers Due to Risk for Patient Complications
Hologic Partners With CDC to Develop Bird Flu Test Reagents
Express News | Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by Cdc
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
UBS Downgrades Hologic(HOLX.US) to Hold Rating, Cuts Target Price to $84
Another Week, Another Index Record | Lkive Stock